USD 14.54
(6.52%)
Year | Inventory | Inventory Growth |
---|---|---|
2023 | - USD | 100.0% |
2022 | -6.62 Million USD | 0.0% |
2021 | - USD | 0.0% |
2020 | - USD | 0.0% |
2019 | - USD | 0.0% |
2018 | - USD | -100.0% |
2017 | 1.00 USD | -100.0% |
2016 | 64 Thousand USD | -65.78% |
2015 | 187 Thousand USD | 4.47% |
2014 | 179 Thousand USD | -49.81% |
2013 | 356.64 Thousand USD | 110.36% |
2012 | 169.53 Thousand USD | 0.0% |
Year | Inventory | Inventory Growth |
---|---|---|
2024 Q1 | 1.00 USD | 0.0% |
2024 Q2 | - USD | -100.0% |
2023 Q2 | - USD | 100.0% |
2023 Q3 | - USD | 0.0% |
2023 Q4 | - USD | 0.0% |
2023 FY | - USD | 100.0% |
2023 Q1 | -8.74 Million USD | -32.02% |
2022 Q1 | - USD | 0.0% |
2022 Q3 | - USD | 0.0% |
2022 Q2 | - USD | 0.0% |
2022 Q4 | -6.62 Million USD | 0.0% |
2022 FY | -6.62 Million USD | 0.0% |
2021 Q1 | - USD | 0.0% |
2021 Q3 | - USD | 0.0% |
2021 Q4 | - USD | 0.0% |
2021 FY | - USD | 0.0% |
2021 Q2 | - USD | 0.0% |
2020 Q1 | 1.00 USD | 0.0% |
2020 Q2 | - USD | -100.0% |
2020 FY | - USD | 0.0% |
2020 Q4 | - USD | 0.0% |
2020 Q3 | - USD | 0.0% |
2019 Q2 | 1.00 USD | 0.0% |
2019 FY | - USD | 0.0% |
2019 Q4 | - USD | 0.0% |
2019 Q3 | - USD | -100.0% |
2019 Q1 | - USD | 0.0% |
2018 FY | - USD | -100.0% |
2018 Q1 | 1.00 USD | 0.0% |
2018 Q3 | 1.00 USD | 0.0% |
2018 Q4 | - USD | -100.0% |
2018 Q2 | 1.00 USD | 0.0% |
2017 Q1 | 1.00 USD | -100.0% |
2017 FY | 1.00 USD | -100.0% |
2017 Q4 | 1.00 USD | 0.0% |
2017 Q3 | 1.00 USD | 0.0% |
2017 Q2 | 1.00 USD | 0.0% |
2016 Q3 | 62 Thousand USD | -70.89% |
2016 Q4 | 64 Thousand USD | 3.23% |
2016 Q2 | 213 Thousand USD | -20.82% |
2016 Q1 | 269 Thousand USD | 43.85% |
2016 FY | 64 Thousand USD | -65.78% |
2015 Q4 | 187 Thousand USD | -48.63% |
2015 Q1 | 330 Thousand USD | 84.36% |
2015 FY | 187 Thousand USD | 4.47% |
2015 Q3 | 364 Thousand USD | -32.09% |
2015 Q2 | 536 Thousand USD | 62.42% |
2014 Q4 | 179 Thousand USD | -22.87% |
2014 Q1 | 124.23 Thousand USD | -65.16% |
2014 Q2 | 193.14 Thousand USD | 55.46% |
2014 Q3 | 232.06 Thousand USD | 20.15% |
2014 FY | 179 Thousand USD | -49.81% |
2013 Q4 | 356.64 Thousand USD | 0.0% |
2013 FY | 356.64 Thousand USD | 110.36% |
2012 FY | 169.53 Thousand USD | 0.0% |
Name | Inventory | Inventory Difference |
---|---|---|
Xeris Biopharma Holdings, Inc. | 38.83 Million USD | 100.0% |
Arrowhead Pharmaceuticals, Inc. | - USD | NaN% |
Codexis, Inc. | 2.68 Million USD | 100.0% |
Organovo Holdings, Inc. | 297 Thousand USD | 100.0% |